Chronic Migraine Survey

Market: Pharma & Healthcare

Global, 14 pages report, published by Informa

Report ThumbnailMarch-2017
Datamonitor conducted a 5-question survey of 26 United States and 25 European (based in France, Germany, Italy, Spain and United Kingdom) neurologists involved in pain management to gauge current prescribing practices in prophylactic treatment of chronic migraine and potential future use of the calcitonin gene-related peptide (CGRP) receptor targeting monoclonal antibody (mAb) AMG 334 (AMGN) and CGRP targeting mAbs ALD403 (ALDR) and TEV-48125 (TEVA).


Biomedtracker will be offering KOL R

Read More
  • Survey
Read More

Please select a license type


Recently Viewed

Related Products

InformaChronic Migraine SurveyProduct ThumbnailChronic Migraine Survey, Industry ReportProduct #: 770020
Global Markets Direct
GBI Research
PayPal Acceptance Mark
SSL Certificate
Copyright © 2021 Global Market Analyst. All Rights Reserved